Advertisement

Topics

OpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify ...

02:30 EDT 14 May 2019 | BioMedReports - Blog

GAITHERSBURG, Md., May 14, 2019 (GLOBE NEWSWIRE)

Read more...

Original Article: OpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify ...

NEXT ARTICLE

More From BioPortfolio on "OpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify ..."

Advertisement
Quick Search
Advertisement
Advertisement